Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01031394 · ClinicalTrials.gov registry record · NA

Frequency of Aerobic/Resistance Training in Older Women

A NA study of Aging, sponsored by University of Alabama at Birmingham.

Completed
Registry status
NA
Development phase
105
Enrollment target
1
Study location

NCT01031394: Completed NA study of Aging, sponsored by University of Alabama at Birmingham.

NCT01031394 is a NA study of Aging that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 105 participants, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01031394, a NA study of Aging, has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
NA
Development phase
105 participants
Enrollment target
1
Study location

Study Summary

The objective of this study is to provide insight into the effects combined training frequency has on improving fitness, ease of physical activity, and maintenance of a high total energy expenditure. Such information is critical to our understanding of ways to improve well-being, quality of life, and independence of an aging population. 105 participants will be enrolled in this study. The length of time for your involvement in the study will be 32 weeks. You will undergo the procedures listed in this consent form on 3 separate occasions-initially at your entry, at 16 weeks and again at 32 weeks.

Conditions Studied

Interventions

  • OTHER Frequency of Aerobic/Resistance Training - 3 to 3

Study Locations (1)

Alabama

  • UAB - Birmingham

Trial Details

FieldValue
Enrollment Target 105 participants
Start Date 2004-01
Est. Completion 2011-03
Phase NA
University of Alabama at Birmingham

1,160 total trials

What the finished NCT01031394 record still lists

NCT01031394 is an interventional study that assigns participants to a tested intervention. The registered 105 participants enrollment target is mid-sized for trials with a published cap, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (95% lower).

The record links to 1 condition, with Aging appearing as the primary indexed condition, and to 1 intervention - of which Frequency of Aerobic/Resistance Training - 3 to 3 is the first listed.

NCT01031394 reports a single indexed study location in Alabama.

Frequently Asked Questions

What is clinical trial NCT01031394 about?

NCT01031394 is a clinical study titled "Frequency of Aerobic/Resistance Training in Older Women". The objective of this study is to provide insight into the effects combined training frequency has on improving fitness, ease of physical activity, and maintenance of a high total energy expenditure. Such information is critical to our understanding of ways to improve well-being, quality of life, an...

What is the current status of trial NCT01031394?

This trial is currently completed. It is a NA study. The enrollment target is 105 participants. The study started on 2004-01. Estimated completion is 2011-03.

What conditions does trial NCT01031394 study?

This clinical trial studies the following conditions: Aging.

What interventions are being tested in trial NCT01031394?

The interventions under investigation include: Frequency of Aerobic/Resistance Training - 3 to 3 (OTHER).

Who is sponsoring clinical trial NCT01031394?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01031394 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Aging

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01031394's enrollment target sits among peer trials

105 83rd of 262 higher than 179 of 262 other Aging trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Aging trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04253964 · 105 participants · Phase 2

    Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy

  • NCT04742452 · 105 participants · NA

    Comparison of Partial Rotator Cuff Repair vs. Superior Capsular Reconstruction for Irreparable Rotator Cuff Tears

  • NCT04875429 · 105 participants · NA

    Zenith® Fenestrated+ Clinical Study

  • NCT05428007 · 105 participants · Phase 2

    Interleukin-6 Receptor Inhibitor Sarilumab in Combination With Ipilimumab, Nivolumab and Relatlimab in Patients With Unresectable Stage III or Stage IV Melanoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

Source: ClinicalTrials.gov NCT01031394, the US trial registry maintained by the National Library of Medicine. NCT01031394 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.